NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 3 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $5,000 | -16.7% | 9,575 | 0.0% | 0.00% | – |
Q2 2020 | $6,000 | +20.0% | 9,575 | 0.0% | 0.00% | – |
Q1 2020 | $5,000 | -58.3% | 9,575 | 0.0% | 0.00% | – |
Q4 2019 | $12,000 | -33.3% | 9,575 | +5.8% | 0.00% | -100.0% |
Q3 2019 | $18,000 | +157.1% | 9,050 | +196.7% | 0.00% | – |
Q2 2019 | $7,000 | – | 3,050 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 191,028 | $462,000 | 0.08% |
Sterling Investment Advisors, Ltd. | 5,000 | $12,000 | 0.00% |
IFP Advisors, Inc | 0 | $0 | 0.00% |